Source: Faith Leonard and Gretchen Jacobson, “What Does the Decline in Medicare Part D Plan Availability Mean for ...
The Women in AI Healthcare event series - hosted by Real Chemistry in collaboration with Pharma Brands – brings together ...
Ascentage Pharma's first approved product, Olverembatinib, is the first novel third-generation BCR-ABL1 inhibitor approved in ...
In a Q&A for Fierce Pharma Marketing’s “Rising Stars” series, Andrew Willett discussed the path that led him to Lundbeck and ...
The Kerala University of Health Sciences (KUHS) has announced the examination timetable for B.Pharm students under the 2017 ...
Biostar Pharma, Inc., the U.S. wholly-owned subsidiary of Beijing Biostar Pharmaceuticals Co., Ltd. (Stock Code: 2563.HK), today announced that the first patient has ...
THE COMPANY EXPECTS TO RELEASE TOPLINE RESULTS FOR SKNJCT-003 PHASE 2 CLINICAL TRIAL BEFORE THE END OF Q1 2026 AND REQUEST END-OF-PHASE 2 (EOP2) ...
Maxim Group LLC is acting as the exclusive Financial Advisor for the transaction PHILADELPHIA, PA / ACCESS Newswire / ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results